TrialJAMA oncology2023

Efficacy and Safety of Weekly Paclitaxel Plus Vistusertib vs Paclitaxel Alone in Patients With Platinum-Resistant Ovarian High-Grade Serous Carcinoma: The OCTOPUS Multicenter, Phase 2, Randomized Clinical Trial.

Susana Banerjee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.